Skip to content

Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern

Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03493295
Acronym
BERTA
Enrollment
587
Registered
2018-04-10
Start date
2018-04-25
Completion date
2021-03-15
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Brief summary

The aim of this non-interventional study (NIS) is to assess, under real-life conditions, woman's satisfaction with Levonogestrel IntraUterine System (LNG-IUS) in a young (18-30 years old (y.o.)) Spanish population taking into account their parity status. Furthermore, the study is aimed to evaluate the impact of: menstrual bleeding pattern and satisfaction with it at baseline, LNG-IUS chosen, previously used contraceptive method and reasons for change to/ choice of a LNG-IUS on overall satisfaction with LNG-IUS use.

Interventions

At the routine clinical practice. Jaydess, Mirena, Kyleena Or any other levonogestrel intrauterine system (LNG-IUS) commercialized in Spain at the start of the study, only for contraception indication.

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Women in childbearing age, between 18-30 years old. * Women who have chosen a LNG-IUS as contraceptive method, after been adequately counselled by the physician about all contraceptive possible options. * Women who have chosen a LNG-IUS mainly for contraceptive reasons, not due to heavy menstrual bleeding. * Women with no desire to conceive for at least within the next 12 months. * Women capable of reading and writing

Exclusion criteria

* Women whose main reason to use a LNG-IUS is not a contraceptive reason. * Women with contraindication for LNG-IUS. * Women with previous experience with a IUS. * Women who have been diagnosed with heavy menstrual bleeding. * Women with degenerative or other kind of diseases that could directly negatively impact their daily life. * Women who have undergone a hysterectomy or irreversible contraceptive method. * Women participating in a clinical trial. * Women with a mental illness and unable to make decisions and follow instructions. * Women with amenorrhea * Women with clinical history of severe dysmenorrhea * Women with concomitant medication that may lead changes in bleeding pattern (e.g. antiplatelets and/or anticoagulants)

Design outcomes

Primary

MeasureTime frameDescription
Percentage of subjects rating 1 (very dissatisfied) to 5 (very satisfied) in the 5-point Likert scale overall satisfaction with LNG-IUSAt approximately 12 months(end of observation/final visit)Overall satisfaction with LNG-IUS at end of observation/final visit (i.e. after approximately 12 months or at premature discontinuation). 5 point Likert scale of overall satisfaction with LNG-IUS with end labelling very dissatisfied / very satisfied

Secondary

MeasureTime frameDescription
8 item user satisfaction questionnaire to assess the satisfaction with menstrual bleeding pattern with LNG-IUSAt approximately 12 months(end of observation/final visit)Overall satisfaction with the menstrual bleeding profile with LNG-IUS at end of observation/final visit.
Spearman's correlation between overall satisfaction with LNG-IUS and overall satisfaction with menstrual bleeding patternAt approximately 12 months(end of observation/final visit)
Percentage of subjects rating 1 (very dissatisfied) to 5 (very satisfied) in the 5-point Likert scale overall satisfaction with LNG-IUSAt 4-12 weeks after insertionOverall satisfaction with LNG-IUS 4-12 weeks after insertion. 5 point Likert scale of overall satisfaction with LNG-IUS with end labelling very dissatisfied / very satisfied
Overall satisfaction with the menstrual bleeding profile 4-12 weeks after insertion.At 4-12 weeks after insertion
Ease of LNG-IUS insertion will be measured by investigator on an ordinal scale of easy, slightly difficult, very difficultAt initial visit (Day 0_LNG-IUS insertion)Ease of LNG-IUS insertion assessed by the investigator.
Percentage of women rating 1 (very dissatisfied) to 5 (very satisfied) in the 5-point Likert scale of overall satisfaction with the menstrual bleeding profile with LNG-IUSAt 4-12 weeks after insertion, At approximately 12 months(end of observation/final visit)Overall satisfaction rate with LNG-IUS at end of observation/final visit. 5 point Likert scale of overall satisfaction with the menstrual bleeding pattern with LNG-IUS with end labelling very dissatisfied / very satisfied.
Percentage of women that would recommend a LNG-IUS to peersAt approximately 12 monthsResponse in recommendation to peers item at final visit.
Reasons for change to/ choice a LNG-IUS assessed by a multiple choice itemAt initial visit (Day 0_LNG-IUS insertion)
Descriptive analysis of demographic dataAt initial visit (Day 0_LNG-IUS insertion)Women's profile defined by their sociodemographic and gynaecological characteristics.
Reasons for withdrawalUp to approximately 12 months
Percentage of withdrawalUp to approximately 12 months
Pain at LNG-IUS insertion will be assessed by the clinician asking to the user on a ordinal scale of none, mild, moderate or severeAt initial visit (Day 0_LNG-IUS insertion)Pain at LNG-IUS insertion assessed by the user.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026